Acrivon Therapeutics (ACRV) will be providing ACR-368 and ACR-2316 clinical data and other updates via a press release at 7:30 a.m. ET, and ...
The BigpAK-2 randomized prospective multicenter trial tested implementation of a bundle of measures to prevent acute kidney injury in high-risk patients undergoing major surgery. Trial results support ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback